Abstract
Purpose
Hypoparathyroidism is a rare endocrine disorder for which replacement therapy of the missing parathyroid hormone is not the standard therapeutic option. Current standard treatment consists of calcium and vitamin D supplementation. The intake of calcium and vitamin D supplementation can lead to complications and therefore might negatively influence patients’ quality of life.
Methods
A systematic literature review was performed to assess the current knowledge on the influence of hypoparathyroidism on patients’ quality of life. The literature search was conducted in PubMed and Web of Science; all relevant literature published by August 24, 2016, was included.
Results
In total 372 records were found. After title and abstract screening, 14 studies remained for a full-text screening. The full-text screening resulted in five studies which were included into the systematic review. Comparing the results with a norm-based reference population, three studies reported lower SF-36 scores for hypoparathyroidism patients. Two studies showed a reduced quality of life in hypoparathyroidism patients when their results were compared to control populations.
Conclusion
Most hypoparathyroidism patients receiving standard treatment show stable calcium and vitamin D levels. However, hypoparathyroidism patients still report reduced quality of life and experience physical, mental, and emotional symptoms. Therefore, it is assumed that the lack of parathyroid hormone directly influences the patients’ quality of life. This review indicates that patients with hypoparathyroidism have a reduced quality of life in comparison to norm-based populations or matched controls. Further studies are required to quantify the effect of hypoparathyroidism on patients’ quality of life using disease-specific questionnaires and controlling for the co-morbidities and etiologies of the patients.
Similar content being viewed by others
References
D. Shoback, Clinical practice. Hypoparathyroidism. N. Engl. J. Med. 359(4), 391–403 (2008)
A. Bergenfelz, S. Jansson, A. Kristoffersson, H. Martensson, E. Reihner, G. Wallin et al. Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3660 patients. Langenbecks Arch. Surg. 393(5), 667–673 (2008)
O. Thomusch, A. Machens, C. Sekulla, J. Ukkat, M. Brauckhoff, H. Dralle, The impact of surgical technique on postoperative hypoparathyroidism in bilateral thyroid surgery: a multivariate analysis of 5846 consecutive patients. Surgery 133(2), 180–185 (2003)
L. Underbjerg, T. Sikjaer, L. Mosekilde, L. Rejnmark, Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J. Bone Miner. Res. 28(11), 2277–2285 (2013)
L. Underbjerg, T. Sikjaer, L. Mosekilde, L. Rejnmark, The epidemiology of nonsurgical hypoparathyroidism in Denmark: a nationwide case finding study. J. Bone Miner. Res. 30(9), 1738–1744 (2015)
J. Powers, K. Joy, A. Ruscio, H. Lagast, Prevalence and incidence of hypoparathyroidism in the United States using a large claims database. J. Bone Miner. Res. 28(12), 2570–2576 (2013)
M.C. Astor, K. Lovas, A. Debowska, E.F. Eriksen, J.A. Evang, C. Fossum et al. Epidemiology and health-related quality of life in hypoparathyroidism in Norway. J. Clin. Endocrinol. Metab. 101(8), 3045–3053 (2016)
W. Arlt, C. Fremerey, F. Callies, M. Reincke, P. Schneider, W. Timmermann et al. Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. Eur. J. Endocrinol. 146(2), 215–222 (2002)
G. Marcucci, G. Della Pepa, M.L. Brandi, Natpara for the treatment of hypoparathyroidism. Expert. Opin. Biol. Ther. 16(11), 1417–1424 (2016)
J.P. Bilezikian, A. Khan, J.T. Potts Jr., M.L. Brandi, B.L. Clarke, D. Shoback et al. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J. Bone Miner. Res. 26(10), 2317–2337 (2011)
R. Herzog, M.J. Alvarez-Pasquin, C. Diaz, J.L. Del Barrio, J.M. Estrada, A. Gil, Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Public Health 13, 154 (2013)
N.E. Cusano, M.R. Rubin, D.J. McMahon, D. Irani, A. Tulley, J. Sliney Jr et al. The effect of PTH(1-84) on quality of life in hypoparathyroidism. J. Clin. Endocrinol. Metab. 98(6), 2356–2361 (2013)
T. Sikjaer, L. Rolighed, A. Hess, A. Fuglsang-Frederiksen, L. Mosekilde, L. Rejnmark, Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial. Osteoporos. Int. 25(6), 1717–1726 (2014)
T. Sikjaer, E. Moser, L. Rolighed, L. Underbjerg, L.S. Bislev, L. Mosekilde et al. Concurrent hypoparathyroidism is associated with impaired physical function and quality of life in hypothyroidism. J. Bone Miner. Res. 31(7), 1440–1448 (2016)
J.E. Ware Jr., C.D. Sherbourne, The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 30(6), 473–483 (1992)
J.H. Loge, S. Kaasa, Short form 36 (SF-36) health survey: normative data from the general Norwegian population. Scand. J. Soc. Med. 26(4), 250–258 (1998)
K. Lovas, J.H. Loge, E.S. Husebye, Subjective health status in Norwegian patients with Addison’s disease. Clin. Endocrinol. 56(5), 581–588 (2002)
I. Nermoen, E.S. Husebye, J. Svartberg, K. Lovas, Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway. Eur. J. Endocrinol. 163(3), 453–459 (2010)
N. Hadker, J. Egan, J. Sanders, H. Lagast, B.L. Clarke, Understanding the burden of illness associated with hypoparathyroidism reported among patients in the PARADOX study. Endocr. Pract. 20(7), 671–679 (2014)
A.G. Bago, E. Dimitrov, R. Saunders, L. Seress, M. Palkovits, T.B. Usdin et al. Parathyroid hormone 2 receptor and its endogenous ligand tuberoinfundibular peptide of 39 residues are concentrated in endocrine, viscerosensory and auditory brain regions in macaque and human. Neuroscience 162(1), 128–147 (2009)
S. Balabanov, U. Tollner, H.P. Richter, F. Pohlandt, G. Gaedicke, W.M. Teller, Immunoreactive parathyroid hormone, calcium, and magnesium in human cerebrospinal fluid. Acta Endocrinol. 106(2), 227–233 (1984)
P. Divieti, N. Inomata, K. Chapin, R. Singh, H. Juppner, F.R. Bringhurst, Receptors for the carboxyl-terminal region of pth(1-84) are highly expressed in osteocytic cells. Endocrinology 142(2), 916–925 (2001)
T.B. Usdin, T.I. Bonner, S.R. Hoare, The parathyroid hormone 2 (PTH2) receptor. Recept. Channels 8(3-4), 211–218 (2002)
N.E. Cusano, M.R. Rubin, D.J. McMahon, D. Irani, L. Anderson, E. Levy et al. PTH(1-84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy. J. Clin. Endocrinol. Metab. 99(10), 3694–3699 (2014)
A. Santonati, A. Palermo, E. Maddaloni, D. Bosco, A. Spada, F. Grimaldi et al. PTH(1-34) for surgical hypoparathyroidism: A prospective, open-label investigation of efficacy and quality of life. J. Clin. Endocrinol. Metab. 100(9), 3590–3597 (2015)
N.L. Cho, J. Moalem, L. Chen, C.C. Lubitz, F.D. Moore Jr., D.T. Ruan, Surgeons and patients disagree on the potential consequences from hypoparathyroidism. Endocr. Pract. 20(5), 427–446 (2014)
W. Arlt, F. Callies, J.C. van Vlijmen, I. Koehler, M. Reincke, M. Bidlingmaier et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N. Engl. J. Med. 341(14), 1013–1020 (1999)
P. Saravanan, W.F. Chau, N. Roberts, K. Vedhara, R. Greenwood, C.M. Dayan, Psychological well-being in patients on ‘adequate’ doses of l-thyroxine: results of a large, controlled community-based questionnaire study. Clin. Endocrinol. 57(5), 577–585 (2002)
O. Husson, H.R. Haak, W.A. Oranje, F. Mols, P.H. Reemst, L.V. van de Poll-Franse, Health-related quality of life among thyroid cancer survivors: a systematic review. Clin. Endocrinol. 75(4), 544–554 (2011)
H.C. Hoftijzer, K.A. Heemstra, E.P. Corssmit, A.A. van der Klaauw, J.A. Romijn, J.W. Smit, Quality of life in cured patients with differentiated thyroid carcinoma. J. Clin. Endocrinol. Metab. 93(1), 200–203 (2008)
S. Singer, T. Lincke, E. Gamper, K. Bhaskaran, S. Schreiber, A. Hinz et al. Quality of life in patients with thyroid cancer compared with the general population. Thyroid 22(2), 117–124 (2012)
Acknowledgements
Authors’ roles: All authors contributed to the conception and design of the study. All authors contributed to the acquisition, analysis and interpretation of the data. All authors participated in drafting or critically revising the manuscript and all authors’ approved the final version of the manuscript for submission.
Funding
This study did not receive any funding or grants.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Matthias Buettner has nothing to disclose. Thomas Musholt has nothing to disclose. Susanne Singer reports grants from Pfitzer, outside the submitted work.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Büttner, M., Musholt, T.J. & Singer, S. Quality of life in patients with hypoparathyroidism receiving standard treatment: a systematic review. Endocrine 58, 14–20 (2017). https://doi.org/10.1007/s12020-017-1377-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-017-1377-3